|1.||Hamajima, Nobuyuki: 6 articles (04/2011 - 01/2006)|
|2.||Goto, Yasuyuki: 5 articles (04/2011 - 01/2006)|
|3.||Naito, Mariko: 4 articles (04/2011 - 01/2006)|
|4.||Shimoyama, Tadashi: 3 articles (09/2012 - 04/2009)|
|5.||Fukuda, Shinsaku: 3 articles (09/2012 - 04/2009)|
|6.||Rugge, Massimo: 3 articles (07/2011 - 10/2004)|
|7.||Sugano, Kentaro: 2 articles (07/2015 - 03/2008)|
|8.||Malfertheiner, P: 2 articles (04/2015 - 08/2008)|
|9.||Stolte, Manfred: 2 articles (01/2014 - 01/2011)|
|10.||Sorokina, N N: 2 articles (02/2013 - 01/2013)|
10/01/2006 - "We sought to study the relationship between serum pepsinogens and different histopathologic features of Helicobacter pylori-related chronic gastritis. "
09/01/2001 - "The aim of this study was to evaluate the diagnostic potential of serum pepsinogens I and II in predicting the topography and severity of gastritis in H. "
09/01/2001 - "It has long been recognised that specific patterns of gastritis are linked with different gastroduodenal diseases and that serum pepsinogens vary with the histological state of the gastric mucosa. "
09/01/2001 - "Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy."
11/01/1993 - "Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis."
06/01/2008 - "We evaluated the clinical utility of serum pepsinogens (PG) as a biomarker for screening of atrophic gastritis. "
09/01/2006 - "Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis."
06/01/1996 - "Cases are those who were not diagnosed as having atrophic gastritis in 1991 or 1992 but were diagnosed as having atrophic gastritis in 1995 by the examination of serum pepsinogens. "
01/01/2015 - "Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis."
01/01/2014 - "Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population."
04/01/2011 - "Serum pepsinogens were measured to evaluate gastric atrophy. "
01/01/2009 - "Serum pepsinogens were measured to evaluate gastric atrophy. "
04/01/2008 - "Gastric atrophy was evaluated with serum pepsinogens (PG1<70 ng/ml and PG1/PG2<3). "
04/01/2006 - "Gastric atrophy was evaluated with serum pepsinogens (PGI < 70 ng/dl and PGI/II < 3), and TNF T-1031C and C-857T were genotyped by polymerase chain reaction with confronting two-pair primers (PCR-CTPP). "
01/01/2006 - "Gastric atrophy was evaluated with serum pepsinogens (PGs); PG I, less than 70 ng/dl and PG I/II ratio, less than 3. The genotype frequency of PTPN11 was in Hardy-Weinberg equilibrium: 65.5% for G/G, 30.4% for G/A, and 4.1% for A/A. "
|4.||Stomach Neoplasms (Stomach Cancer)
02/01/1999 - "Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. "
12/01/1995 - "The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). "
01/01/1988 - "[Immunomorphologic study of pepsinogens in stomach cancer]."
07/01/2015 - "Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy."
01/01/2015 - "Serologic screening of gastric cancer (GC) by serum pepsinogens (sPG) levels and Helicobacter pylori (Hp) sero-status, though highly informative, has provided heterogeneous results. "
|5.||Duodenal Ulcer (Curling's Ulcer)
04/01/1990 - "The pattern of serum pepsinogens after stopping the drug was different for duodenal ulcer patients and normal subjects. "
05/01/1983 - "Thirty-three duodenal ulcer patients (group A) were examined for gastric acid secretion capacity and serum group I pepsinogens (PG I) under basal conditions. "
02/01/1982 - "Duodenal pepsinogens in experimental duodenal ulcer in rats."
05/01/1983 - "Serum group I pepsinogens in unoperated duodenal ulcer patients and in duodenal ulcer patients after proximal gastric vagotomy."
01/01/1985 - "Immunoperoxidase staining for human group I and group II pepsinogens (PG I, PG II) was performed on stomachs including surgically removed 42 Borrmann IV type gastric carcinomas (B-IV), 6 duodenal ulcers and 6 autopsy cases of traffic accident. "
|1.||gastrin 17 (G 17)
|4.||Biological Markers (Surrogate Marker)
|5.||Pepsinogen A (Pepsinogen)
|8.||beta Carotene (Betacarotene)
|1.||Proximal Gastric Vagotomy